In non‐small‐cell lung cancer (NSCLC), USP44 inhibits NSCLC cell growth via repressing AKT signaling through PTEN stabilization (Zhang, Tian, Zhang, Zhang, & Ma, 2019). The gene discussed is USP44; the disease is non-small cell lung carcinoma.